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ABSTRACT
The GINS complex, originally discovered in
Saccharomyces cerevisiae and Xenopus laevis,
binds to DNA replication origins shortly before the
onset of S phase and travels with the replication
forks after initiation. In this study we present a
detailed characterization of the human GINS
(hGINS) homolog. Using new antibodies that allow
the detection of endogenous hGINS in cells and
tissues, we have examined its expression, abun-
dance, subcellular localization and association
with other DNA replication proteins. Expression of
hGINS is restricted to actively proliferating cells.
During the S phase, hGINS becomes part of a
Cdc45–MCM–GINS (CMG) complex that is
assembled on chromatin. Down-regulation of
hGINS destabilizes CMG, causes a G1–S arrest and
slows down ongoing DNA replication, effectively
blocking cell proliferation. Our data support the
notion that hGINS is an essential component of
the human replisome.
INTRODUCTION
Eukaryotic DNA replication depends on multi-protein
complexes that are assembled at the origins in two steps.
The ﬁrst one is referred to as ‘origin licensing’ and takes
place at the M/G1 transition, when the combined action of
the origin recognition complex (ORC), Cdc6 and Cdt1
proteins engage the Mini-chromosome maintenance com-
plex (Mcm2-7; referred through the text as MCM) with
the DNA. The second step occurs upon activation of the S
phase-promoting cyclin-dependent kinases (CDK) and
Dbf4-dependent kinase (DDK), which trigger the recruit-
ment of additional initiator proteins. In Saccharomyces
cerevisiae, phosphorylation of Mcm4 by DDK facilitates
the binding of Cdc45 (1), which interacts with Sld3 (2).
Phosphorylation of Sld3 and its related protein Sld2 by
CDK creates a binding site for Dpb11 protein (3,4), which
in turn serves as an anchor for DNA polymerases, RPA
and the GINS complex. GINS is formed by proteins Sld5
(synthetic lethal with Dpb11), Psf1, Psf2 and Psf3 [part-
ners of Sld-ﬁve; (5–7)]. Some of these factors, e.g. MCM,
Cdc45 and GINS are involved in the initiation reaction
and later become part of the replisome machinery (8–10);
reviewed by (11–14). In mammalian cells, oncogenes such
as Cyclin E interfere with this pathway of origin activa-
tion, causing an ineﬃcient S phase and genomic damage
(15); reviewed by (16).
Most of the proteins involved in the licensing step
(ORC, Cdc6 and MCM) are conserved in eukaryotic
organisms and have recognizable ancestors in archaea.
This is not always the case for the initiators acting at the
G1–S transition: yeast Dpb11 and Sld2 proteins are
related to mammalian TopBP1 and RecQ4L, respectively,
but the latter are much larger and contain additional
domains that could serve other cellular functions. Sld3
has no evident homologs outside fungi, at least at the
amino acid sequence level. In contrast, the GINS complex
is highly conserved and the mammalian paralogues of its
four subunits have been identiﬁed by sequence homology
(6,7). We have recently cloned the four subunits of human
GINS (hGINS), reconstituted the recombinant protein
complex and proposed its 3D volume based on electron
microscopy imaging (17). In this report we turn to the
characterization of endogenous hGINS, analyzing its
expression, abundance, regulation in the cell division
cycle and interactions with other DNA replication
proteins.
MATERIALS AND METHODS
Proteinpurification and antibody production
Recombinant hGINS, puriﬁed as described (17), was used
to immunize Balb/c mice. Three hybridoma cell lines were
selected that produced monoclonal antibodies against Psf1
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Polyclonal antibodies against Psf1 and Psf3 were generated
using synthetic peptides conjugated to KLH protein
(Pierce): N-CQITASNLVQNYKKRKF-C (Psf1); N-LL
KKNSQHFLPRWCK-C (Psf3). Polyclonal antibodies
against Sld5, Psf2 and Cdc45 were raised in rabbits injected
with recombinant Sld5, Psf3 and Cdc45 (amino acids
388–566) puriﬁed from Escherichia coli as GST fusions.
Other antibodies used in this study were: Orc2, Mcm2-7
and PCNA, kindly provided by B. Stillman (Cold Spring
Harbor Laboratory, NY, USA), CDC6 and g-H2AX
(DCS-180 and JBW301; Upstate Biotechnology), DNA
polymerase d and Cyclin B1 (H-300 and GNS1; Santa
Cruz Biotechnology), Mek2, p27 and FITC-BrdU
(BD-610235, BD-554069 and BD-556028, BD Sciences
Pharmingen), T7 (69522, Novagen), Chk1P-S345
(133D3, Cell Signaling Technology), a-tubulin (DM1A,
Sigma), H3 (Ab1791, Abcam), GAPDH (CNIO Monoclo-
nal Antibody Unit). Secondary antibodies for immunoblot
and immunoﬂuorescence (IF) were from Amersham and
Jackson Immunoresearch Inc., respectively.
Cellculture andmanipulations
IMR90, Wi-38, BJ-hTERT, HeLa, U2OS and 293T cell
lines were grown in DMEM–10% FBS with penicillin and
streptomycin. K562 and Jurkat were grown in RPMI
1630-10% FBS plus antibiotics. To drive BJ-hTERT
cells into a quiescent state by contact inhibition, cells
were grown to conﬂuency and kept for 72h before collec-
tion. G0 cells were driven back into S phase by re-plating
the conﬂuent culture (1:2 split). Cells were collected 24h
later.
Transfection of plasmidic DNA into HeLa cells was
carried out with Lipofectamine 2000 (Invitrogen).
Stealth siRNA duplexes directed to SLD5, PSF1, PSF2
or PSF3 (sequences available upon request) were trans-
fected twice at a ﬁnal concentration of 100nM, using
oligofectamine (Invitrogen). Cell cycle synchronization
was achieved by thymidine block and release (18). The
biochemical fractionation to separate soluble and chroma-
tin-associated proteins was performed as described (19).
For the detection of DNA replication foci, cells were
incubated for 10min with 10mM EdU (20) prior to ﬁxa-
tion with 2% PFA. EdU incorporation was visualized
using Click-IT EdU AF647 (Invitrogen).
Immunological detection of proteins in cells andtissues
Standard protocols for immunoblotting, immunoprecipi-
tation (IP), indirect IF and immunohistochemistry (IHC)
were followed. When indicated, immunoblotting signals
were quantiﬁed using ImageJ software (U.S. National
Institutes of Health, Bethesda, MD, USA, http://
rsb.info.nih.gov/ij/). Prior to IP, whole cell extracts were
prepared in 50mM Tris HCl pH 7.5, 150mM NaCl, 1%
Triton X-100, 5mM NaF, 5mM 2-glycerol phosphate,
1mM NaVO4, 1mM 1,4-dithiothreitol, 1mM PMSF
and a protease inhibitor cocktail (Roche). Cell lysis
proceeded for 20min on ice and was followed by brief
sonication. For soluble extracts and digested chromatin
extracts, cells were lysed in 10mM HEPES pH 7.9,
0.2M KOAc, 0.1% Triton X-100, 0.34M sucrose, 10%
glycerol, 1mM 1,4-dithiothreitol, protease and phospha-
tase inhibitors as above. After a 5min spin at 800g, the
fraction corresponding to the soluble (cytosol/extracted
nucleoplasm) proteins was recovered. The chromatin
fraction in the pellet was incubated with micrococcal
nuclease (Sigma N3755; 0.33U/10
6cells) for 20min at
248C. Insoluble material was removed from all fractions
by centrifugation at 16000g for 30min.
Flow cytometry analyses
Cells were ﬁxed in 70% ethanol and washed in PBS-0.05%
Tween-20. To measure DNA content, cells were treated
with 20mg/ml propidium iodide and 100mg/ml RNaseA.
For BrdU detection, 10mM BrdU was added to the
medium for 60min prior to cell collection. Cells were
ﬁxed and washed as above, treated with 4M HCl/0.5%
Triton X-100 for 20min and incubated with FITC-conju-
gated anti-BrdU antibody. Cells were processed in a
FACScalibur cytometer (BD Biosciences).
RESULTS
Immunodetection ofendogenous hGINS incells and tissues
Recombinant hGINS complex was puriﬁed through aﬃ-
nity, ion-exchange and gel-ﬁltration chromatographic
steps (Figure 1A), as previously described (17) and used
as antigen to generate monoclonal antibodies in mice. In
addition, polyclonal antibodies were raised using recom-
binant Sld5 and Psf2 proteins or synthetic peptides cor-
responding to Psf1 and Psf3 (see Materials and methods
section). All the new antibodies detected the correspond-
ing endogenous hGINS subunits from whole cell extracts
in immunoblot assays (Figure 1B), and some of them were
suitable for IP, IF and IHC studies.
The four subunits of hGINS form a stable complex that
can be recovered from cell extracts by IP with a Psf2
monoclonal antibody (Figure 1C, lane 3). Virtually the
entire amounts of the four hGINS subunits were precipi-
tated (Figure 1C, compare lanes 3 and 5). Furthermore,
the complex was detected at all stages of the cell division
cycle (Supplementary Figure 1). DNA replication proteins
Mcm2 or DNA polymerase d did not co-precipitate with
hGINS in a whole cell extract, but an interaction between
hGINS and MCM was observed on chromatin (see
subsequently). hGINS is a nuclear protein, as revealed
by indirect IF in HeLa cells (Figure 1D, panels i–ii). The
speciﬁcity of the IF staining was conﬁrmed by down-
regulation of PSF2 expression by RNAi (Figure 1D,
panels iii–iv). The eﬀects of hGINS down-regulation are
discussed in a later section.
hGINS could also be detected in human tissues by IHC
with a Psf1 monoclonal antibody. In a tonsil sample, Psf1
was more abundant in the proliferating lymphocytes of
the germinal center, compared with the interfollicular
tissue surrounding it (Figure 1E, left panel). This staining
pattern, similar to that of Mcm3 protein (Figure 1E, right
panel), indicates that hGINS is a useful marker of cell
proliferation.
2088 Nucleic Acids Research, 2009, Vol. 37,No. 7hGINS expression correlates withcell proliferation
Using deﬁned amounts of recombinant hGINS as refer-
ence, we estimated that diploid IMR90 and Wi-38 lines
contain between 85000 and 130000 molecules of hGINS
per cell. hGINS is more abundant in immortalized
BJ-hTERT ﬁbroblasts (220000 molecules/cell) and
tumor-derived cell lines such as Jurkat, K562, HeLa,
U2OS and 293T (500000–1100000 molecules/cell;
Figure 2A). The promoter regions of hGINS genes include
binding sites for multiple transcription factors, notably
E2F-1 and Myc-Max (21), which are frequently deregu-
lated in cancer (Supplementary Figure 2A).
In diploid ﬁbroblasts driven into G0 by contact inhibi-
tion, the four hGINS subunits were virtually undetectable
(Figure 2B). As expected, the levels of DNA replication
factors Cdc6, MCM and Cdc45 and mitotic cyclin B1 were
also reduced in the quiescent state, whereas the concen-
tration of CDK inhibitor p27 was increased. Other DNA
replication factors such as Orc2 or PCNA were not
degraded after 3 days in G0 (Figure 2B). The strong
Figure 1. Immunodetection of endogenous hGINS in cells and tissues. (A) Coomassie staining of puriﬁed recombinant hGINS complex. (B)
Immunoblot detection of hGINS subunits in 293T whole cell extracts with the indicated antibodies. (C) IP of the endogenous hGINS complex
from HeLa whole cell extracts. Immunoblot detection of Sld5, Psf1, Psf2 and Psf3 after IPs with control IgG or anti-Psf2 monoclonal antibody.
Input lane contains 2% of the extract amount used in each IP. FT, ﬂow through (2% of the amount used in each IP). Asterisks indicate cross-
reactions with the IgG light chain. (D) IF detection of Psf2 (green) and DNA staining (gray) in cells treated with control or PSF2 siRNA molecules.
Bar, 20mm. (E) Immunohistochemical detection of Psf1 and Mcm3 proteins in biopsies of human tonsil. Brown peroxidase staining indicates the
presence of the target protein. Dashed lines mark the tonsil germinal centers of proliferating lymphocytes.
Nucleic Acids Research,2009, Vol.37, No. 7 2089down-regulation of hGINS was likely the result of
transcriptional repression and the proteolytic degradation
of existing hGINS complexes. Protein degradation may
be relatively rapid because the half-life of hGINS sub-
units is in the 6–8h range, similar to that of cyclins
(Supplementary Figure 2B). Interestingly, 24h after
re-plating the contact-inhibited cell population at a
lower density, the four components of hGINS were
expressed again, as well as Cdc6, MCM and Cdc45
(Figure 2B). This result conﬁrms that hGINS expression
is linked to cell proliferation.
hGINSis essential forinitiation of DNA replication
andS phaseprogression
We next evaluated whether hGINS is directly involved in
cellular processes necessary for proliferation and viability.
Small interference RNA (siRNA) molecules designed
against each one of its subunits reduced the amount
of hGINS to <10% of its normal levels in HeLa cells
(Figure 3A). Silencing the expression of any individual
subunit triggered the concomitant degradation of the
others, indicating that the stability of hGINS components,
particularly Sld5 and Psf3, depends on the formation of
the full complex. Indeed, hGINS down-regulation pre-
vented cell proliferation (Figure 3B). Because no cell
death was observed for the duration of the experiment,
the failure to proliferate suggests a block in cell cycle
progression.
The eﬃciency of DNA replication in cells with reduced
levels of hGINS was ﬁrst estimated by IF after the incor-
poration of a nucleotide analog onto nuclear DNA. After
a pulse of 10min with EdU (20), 28% of the cells in the
control population scored positive for replication com-
pared with 4% of the cells treated with SLD5 or PSF1
siRNA molecules (Figure 4A). The incorporation of
nucleotide analogues was also analyzed by ﬂow cytometry
to visualize the diﬀerent phases of the cell cycle
(Figure 4B). In the control population, the intensity of
Figure 3. hGINS is essential for cell proliferation. (A) Immunoblot
detection of hGINS subunits in HeLa cell extracts prepared 72h
after transfection of control or two independent (a/b) siRNA oligonu-
cleotides for each subunit. Diﬀerent amounts of control HeLa cell
extracts were loaded as standard. a-Tubulin is shown as loading
control. (B) Proliferation curves after hGINS down-regulation. HeLa
cells transfected with control or hGINS siRNAs were collected at the
indicated time points to measure cell density. Curves represent the
average of three independent experiments.
Figure 2. hGINS expression is linked to proliferation. (A) Abundance
of hGINS in diﬀerent cell lines. Immunoblot detection of Psf1 in whole
cell extracts prepared from 50000 cells of each cell line. The indicated
amounts of recombinant GINS were used as reference. Levels of
GAPDH are shown as loading control. (B) Immunoblot detection of
hGINS subunits and the indicated proteins in asynchronously prolifer-
ating (A), quiescent (G0) and re-plated (R) BJ-hTERT ﬁbroblasts.
2090 Nucleic Acids Research, 2009, Vol. 37,No. 7Figure 4. hGINS is required for initiation and elongation of DNA replication. (A) EdU incorporation assay. HeLa cells, transfected with control,
SLD5 or PSF1 siRNAs, were labeled for 10min with EdU. Psf2 was visualized by indirect IF (green), EdU foci by an alkyl-azide reaction (red) and
DNA by DAPI staining (gray). As a negative control, cells were treated for 4h with 4mM hydroxyurea (HU) prior to the EdU pulse. Bar, 50mm.
(B) Flow cytometry detection of BrdU incorporation. HeLa cells transfected with the indicated siRNAs were labeled with BrdU for 60min prior
to ﬁxation. BrdU intensity is represented in the logarithmic y-axis and DNA content on the linear x-axis. Gates deﬁne the percentage of cells in G1,
G1/S, S (BrdU positive) and G2/M. Similar analysis of a control cell population not labeled with BrdU is shown. (C) S-phase progression assay.
Cells treated with control, SLD5 or PSF1 siRNAs were synchronized at the G1/S transition and released for the indicated times. S-phase progression
was monitored by the analysis of DNA content by ﬂow cytometry.
Nucleic Acids Research,2009, Vol.37, No. 7 2091BrdU incorporation in cells with 1C DNA content (left
part of the horseshoe shape) reﬂects a rapid transition
from G1 into S phase. In contrast, hGINS down-
regulation caused 25–32% of the cells to accumulate at
the G1/S transition, compared with 5.8% of the control
population. As a consequence, a reduced percentage of
cells (13–16%) progressed into S phase, compared with
38% in the control (Figure 4B).
To analyze whether hGINS was also required during S
phase progression, control or siRNA-treated cells were
synchronized at G1/S. Upon release from the block, con-
trol cells initiated and completed S phase in a period of 6h
(Figure 4C, left panel). In contrast, the majority of cells
depleted of hGINS did not progress into S phase and the
fraction of cells that started DNA replication took longer
than 9h to complete it (Figure 4C, mid and right panels).
This result is consistent with hGINS also participating in
the elongation phase of DNA replication. Alternatively,
the delay in S phase completion could be caused by a
reduction in the number of active origins. We have also
observed that cells treated with hGINS RNAi displayed
g-H2AX foci and activated checkpoint kinase Chk1
(Supplementary Figure 3), suggesting an accumulation
of DNA damage as a consequence of defective DNA
replication.
hGINSassociates with chromatinduring
Sphaseand binds to Cdc45/MCM
The cellular levels of hGINS remained constant in the cell
cycle, as determined by immunoblots in cells synchronized
in G1, S or G2/M (Figure 5A, WCE panel). However, a
biochemical fractionation that separates soluble from
chromatin-bound proteins (19) revealed that a fraction
of hGINS associated with chromatin speciﬁcally during
S phase (Figure 5A). This pattern of chromatin associa-
tion was also observed with DNA polymerase processivity
factor PCNA (Figure 5A) and suggests the participation
of hGINS in the replisomes.
In Drosophila, GINS associates with Cdc45 and MCM
proteins in the so-called CMG (Cdc45–MCM–GINS)
complex, which displays DNA helicase activity in vitro
(22). Despite the relevance of this ﬁnding, the formation
of such a CMG complex in mammalian cells remained
to be conﬁrmed. Using cells synchronized in S phase,
we observed that the IP of Mcm3 co-precipitated Cdc45
and hGINS subunits from nuclease-treated chromatin
extracts, but not from soluble cytosol/nucleoplasm
extracts (Figure 5B). This result is consistent with the
existence of a human CMG complex, which appears to
be assembled on chromatin. In contrast, hGINS anti-
bodies failed to co-precipitate MCM or Cdc45 (data not
shown). Because the same antibodies precipitated soluble
hGINS (Figure 1C), this negative result could be
explained if the recognition of hGINS epitopes disrupted
the interactions with other components of hCMG.
hGINSstabilizes theCdc45–MCM interaction
As shown above, Cdc45 and GINS were detected after
the IP of MCM in a nuclease-digested chromatin extract.
This result might reﬂect the formation of a ternary CMG
Figure 5. hGINS associates with MCM and CDC45 proteins on chro-
matin. (A) hGINS binds to chromatin during S phase. The indicated
proteins were detected by immunoblots in whole cell extracts (WCE),
soluble and chromatin fractions from cells synchronized at diﬀerent
stages of the cell cycle. The DNA content of the synchronized fractions
is shown. Mek2, a cytosolic kinase, and Orc2, a chromatin-associated
protein, are shown as controls of the subcellular fractionation protocol.
(B) Detection of the human CMG complex. IPs with control or Mcm3
antibodies were carried out in a soluble (cytosol/extracted nucleoplasm)
extract or a nuclease-treated chromatin extract from HeLa cells
synchronized in S phase. The indicated proteins were detected by
immunoblot. Input represents 0.6% of the amount of extract used in
the IP.
2092 Nucleic Acids Research, 2009, Vol. 37,No. 7complex but could also be explained by the formation of
independent MCM–Cdc45 and MCM–GINS complexes.
In the latter case, the cellular abundance of GINS proteins
should not aﬀect the MCM–Cdc45 interaction. Therefore,
an experiment was designed to check the integrity of the
MCM–Cdc45 interaction after GINS down-regulation. A
T7-tagged version of Cdc45 was transfected into HeLa
cells treated with control or Psf1 siRNAs (Figure 6A).
In control cells, an antibody directed to T7 co-precipitated
subunits of MCM and GINS from solubilized chromatin
(Figure 6B, lane 5), consistent with the result shown
in Figure 5B. The eﬃciency of co-precipitation of GINS
and MCM was signiﬁcantly reduced after a partial down-
regulation of Psf1 (Figure 6B, lane 6; see quantiﬁcation
in bar graph). This result suggests that hGINS may act as
a molecular bridge between Cdc45 and MCM, or at least
stabilize their interaction.
DISCUSSION
The GINS complex was discovered in 2003 as an essential
DNA replication factor in yeast and Xenopus, and its
human homolog has remained largely uncharacterized
except for the elucidation of its 3D structure (17,23–25).
In this study, we have gained new insights into the func-
tion and regulation of endogenous hGINS. First, we
observed a correlation between hGINS abundance and
cell proliferation. In cultured cells, the four components
of hGINS are expressed during mitotic cycles, degraded
shortly after the cells are driven into G0, and resynthesized
upon re-entry in the cell cycle. In tissue sections, hGINS
antibodies stain preferentially the areas with active
proliferation, such as the germinal centers of the tonsil.
In addition, hGINS is more abundant in cancer cell lines
than in primary, diploid lines. Consistent with this obser-
vation, hGINS is up-regulated in gene-expression proﬁles
of intrahepatic cholangiocarcinomas (26) and melanomas
(27). Therefore, hGINS is a good proliferation marker
and its immunodetection may become useful in cancer
diagnosis.
In yeast, GINS participates in origin activation and
then becomes part of the ‘replisome progression complex’
(RPC) traveling with the forks (8,28,29). In human cells,
down-regulation of hGINS expression impaired entry into
S phase as well as S phase progression, suggesting that
hGINS participates in both initiation and elongation of
DNA replication.
hGINS interacts with DNA replication factors MCM
and Cdc45 in chromatin during S phase. This is relevant
because previous work in Drosophila has suggested that a
complex formed by Cdc45, MCM and GINS (CMG)
could constitute the replicative DNA helicase (22).
MCM2-7 may hydrolyze ATP to provide the energy
required for DNA melting, with Cdc45 and GINS playing
structural roles. Actually, hGINS is required to maintain
the stability of the MCM–Cdc45 interaction, a ‘bridge’
function that seems to be evolutionary conserved from
yeast to human (8). Binary interactions between human
Cdc45–MCM and Cdc45–GINS have been recently
reported (30), but we provide new data that strongly sup-
port the existence of a CMG complex in human cells.
An additional insight into the possible function of
GINS at the fork comes from studies in the archaea
Sulfolobus solfataricus. In this organism, GINS associates
with the archaeal MCM and primase complexes, suggest-
ing that it might somehow coordinate the DNA helicase
tracking along the leading strand with the DNA primase
Figure 6. hGINS is required for the stability of the CMG complex. (A)
Experimental design. (B) Immunoblot detection of components of the
CMG complex after the IP with anti-T7 antibody in cells treated with
control or hPsf1 siRNA. Input and FT (ﬂow through) lanes contain
5% of the extract used in the IP. The bar graph represents the ‘relative
IP eﬃciency’ for the indicated proteins. Absolute IP eﬃciency was
calculated in each case as the ratio between the amount of protein
detected in the immunoprecipitate and the total amount in the input.
For a given protein, ‘relative IP eﬃciency’ was estimated as the ratio
between the IP eﬃciencies in cells treated with Psf1 siRNA and control
cells.
Nucleic Acids Research,2009, Vol.37, No. 7 2093that synthesizes short RNA primers at the lagging strand
(31). Interestingly, a physical interaction between hGINS
and DNA polymerase a/primase has been revealed by
surface plasmon resonance and hGINS seems to stimulate
DNA polymerase a/primase activity in vitro (32). Finally,
it should also be considered that hGINS can bind to
single-stranded DNA (ssDNA) or ss/double-stranded
DNA (ss/dsDNA) duplexes and may participate actively
in the DNA unwinding reaction, possibly acting as a
‘molecular ploughshare’ (11,17,33). Combining these
observations, we support a model (Figure 7) in which
GINS is an essential component of the eukaryotic
replisome, on one hand as a key element of the DNA
helicase complex that generates the two template strands,
and on the other hand facilitating the recruitment and/or
activity of the DNA polymerase a/primase that operates
at the lagging strand.
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